Homozygous embryos show defects in the somatic musculature. 67.9% of embryos have missing muscles, 83% have muscle attachment defects and 18.9% have duplicated muscles. 46.5% of embryos have muscle defects in at least 2 hemisegments.
akirinKG01343/akirinEP906 embryos show defects in the somatic musculature. 71.4% of embryos have missing muscles, 68.5% have muscle attachment defects and 25.7% have duplicated muscles. 67% of embryos have muscle defects in at least 2 hemisegments.
akirinKG01343, twi1/twi[+] has embryonic/larval somatic muscle cell phenotype
akirinKG01343, brmI21/brm[+] has embryonic/larval somatic muscle cell phenotype
akirinKG01343, osa[+]/osa308 has embryonic/larval somatic muscle cell phenotype
akirinKG01343, polybromo[+]/polybromoΔ86 has embryonic/larval somatic muscle cell phenotype
akirinKG01343, mor[+]/mor1 has embryonic/larval somatic muscle cell phenotype
Snr101319/Snr1[+], akirinKG01343 has embryonic/larval somatic muscle cell phenotype
akirinKG01343/+ results in disruption of the somatic muscle pattern when in double heterozygous combination with one of the following (% of stage 16 embryos with missing, misattached or duplicated muscles in at least 2 hemisegments is given in parentheses): twi1 (21.6%), brmI21 (35%), osa308 (42%), polybromoΔ86 (38%), mor1 (40%) or Snr101319 (45%).